gallium Ga 68-edotreotide

DRUG4 trials

Sponsors

Sue O'Dorisio, University of California, San Francisco, M.D. Anderson Cancer Center

Conditions

Acoustic SchwannomaAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic MeningiomaAdult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Choroid Plexus TumorAdult Craniopharyngioma

Early Phase 1

68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

TerminatedNCT03001349

M.D. Anderson Cancer CenterMeningioma, Metastatic Well Differentiated Neuroendocrine Neoplasm, Multiple Endocrine Neoplasia Type 1 +3

Start: 2017-05-16End: 2021-02-05Updated: 2021-02-15

Phase 1

GA-68 DOTA-TOC of Somatostatin Positive Malignancies

TerminatedNCT02177773

University of California, San FranciscoCarcinoid Tumors, Neuroblastoma, Neuroendocrine Tumor +1

Start: 2014-06-23End: 2017-08-07Updated: 2019-11-12

Phase 2

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

CompletedNCT01869725

Sue O'DorisioAdult Medulloblastoma, Childhood Medulloblastoma, Neuroblastoma +2

Start: 2013-04-01End: 2018-12-26Updated: 2021-09-22

Unknown Phase

Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors

WithdrawnNCT02194452

Sue O'DorisioAcoustic Schwannoma, Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma +92

Start: 2013-09-30End: 2017-03-31Updated: 2017-04-28